Phase Ib trial of inhaled iloprost for the prevention of lung cancer with predictive and response biomarker assessment.
Miller YE, Ghosh M, Merrick DT, Kubala B, Szabo E, Bengtson L, Kocherginsky M, Helenowski IB, Benante K, Schering T, Kim J, Kim H, Ha D, Bergan RC, Khan SA, Keith RL.
Miller YE, et al. Among authors: bengtson l.
Front Oncol. 2023 Aug 30;13:1204726. doi: 10.3389/fonc.2023.1204726. eCollection 2023.
Front Oncol. 2023.
PMID: 37711198
Free PMC article.